Centessa Pharmaceuticals (CNTA) Payables: 2022-2025
Historic Payables for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to $8.7 million.
- Centessa Pharmaceuticals' Payables rose 16.66% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.6 million, marking a year-over-year decrease of 16.92%. This contributed to the annual value of $7.1 million for FY2024, which is 39.54% down from last year.
- Per Centessa Pharmaceuticals' latest filing, its Payables stood at $8.7 million for Q3 2025, which was up 52.55% from $5.7 million recorded in Q2 2025.
- In the past 5 years, Centessa Pharmaceuticals' Payables registered a high of $14.4 million during Q1 2023, and its lowest value of $5.1 million during Q1 2025.
- In the last 3 years, Centessa Pharmaceuticals' Payables had a median value of $7.5 million in 2024 and averaged $8.6 million.
- Its Payables has fluctuated over the past 5 years, first soared by 114.80% in 2023, then crashed by 52.01% in 2024.
- Quarterly analysis of 4 years shows Centessa Pharmaceuticals' Payables stood at $13.8 million in 2022, then dropped by 14.61% to $11.8 million in 2023, then plummeted by 39.54% to $7.1 million in 2024, then rose by 16.66% to $8.7 million in 2025.
- Its Payables stands at $8.7 million for Q3 2025, versus $5.7 million for Q2 2025 and $5.1 million for Q1 2025.